4 models fit The Campbell's Company Common Stock and they disagree: 0 of 4 land within 15% of the average.
Two or more of our models back this value.
Near fair value(i)Silver66
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionThe Campbell's Company Common Stock (CPB)
Fair value (4 models)
$23.58
ACCE price target
$19.20
Rating
Fairly valued
Horizon
12 months
Fair value published on 17 Oct 2026, 00:00 CEST; previously $29.56 since 12 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $20.00 since 21 May 2026, 00:00 CEST.
Price used: $20.73 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, Dividend discount, EV/EBITDA comparison, Graham number, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
12.1% below
+13.7% to fair value
ACCE score
53
out of 100
Analysts
5% buy
20 covering
P/E
15.0x
forward 11.9x
1-year return
-33.2%
Dividend yield
7.98%
The Campbell's Company Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
The Campbell's Company makes Goldfish crackers, Pepperidge Farm cookies, V8 juice, Rao's pasta sauce, and Campbell's soups, sold mostly through US grocery and mass retail. The main structural asset is brand strength in shelf-stable snacks and sauces, where Rao's in particular has been taking share. The near-term issue is that revenue fell 7.9% year on year, so the case rests on whether volumes stabilise and the cost programme protects a 10.2% operating margin. At a trailing P/E of 15.2 and a forward P/E of 11.9, the market is pricing in continued decline, which makes the stock worth a closer look if you believe the top line is near its trough. The 50/100 score and absence from any major index reflect the revenue contraction, so the work to do is separating cyclical volume weakness from share loss.
Campbell's $CPB posted EPS of $0.51 vs $0.74 a year ago, a 31.1% drop. Revenue also fell 4.5% YoY. ACCE score sits at 42. Here's what the numbers show.
2026-06-08
Recommendation history, last 12 months
Date
Type
New
Previous
Price
18 Oct 2026, 00:00 CEST
ACCE price target
$19.20
$20.00
$19.87
17 Oct 2026, 00:00 CEST
Fair value
$23.58
$29.56
$19.84
12 Oct 2026, 00:00 CEST
Fair value
$29.56
$31.10
$19.21
29 Sept 2026, 00:00 CEST
Fair value
$31.10
$31.58
$19.37
15 Sept 2026, 00:00 CEST
Fair value
$31.58
$32.31
$21.00
8 Sept 2026, 00:00 CEST
Fair value
$32.31
$35.28
$21.38
6 Sept 2026, 00:00 CEST
Fair value
$35.28
$38.78
$21.38
1 Sept 2026, 00:00 CEST
Fair value
$38.78
$38.07
$23.39
29 Aug 2026, 00:00 CEST
Fair value
$38.07
$39.01
$23.31
26 Aug 2026, 00:00 CEST
Fair value
$39.01
$30.93
$24.10
Price
-33.0% · 1Y
Ask anything about CPB
Answered from The Campbell's Company Common Stock fundamentals + recent valuations. Every number shows its source and date.